Cargando…

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain

Pregabalin is a commonly used therapy currently recommended as first-line treatment for a number of neuropathic pain (NeP) conditions. Since licensure, a number of clinical trials of pregabalin in different NeP conditions have been completed from which additional data on safety and tolerability can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freynhagen, Rainer, Serpell, Michael, Emir, Birol, Whalen, Ed, Parsons, Bruce, Clair, Andrew, Latymer, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320770/ https://www.ncbi.nlm.nih.gov/pubmed/24279736 http://dx.doi.org/10.1111/papr.12146

Ejemplares similares

Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials
por: Freeman, Roy, et al.
Publicado: (2015)

Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials
por: Serpell, Michael, et al.
Publicado: (2017)

Improvement in pain severity category in clinical trials of pregabalin
por: Parsons, Bruce, et al.
Publicado: (2016)

Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin
por: Parsons, Bruce, et al.
Publicado: (2015)

Pain relief and functional improvement in patients with neuropathic pain associated with spinal cord injury: an exploratory analysis of pregabalin clinical trials
por: Sadosky, Alesia, et al.
Publicado: (2016)

Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review
por: Freynhagen, Rainer, et al.
Publicado: (2016)

Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy
por: Alexander, Joe, et al.
Publicado: (2017)

The relationship between the reporting of euphoria events and early treatment responses to pregabalin: an exploratory post-hoc analysis
por: Parsons, Bruce, et al.
Publicado: (2019)

Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial
por: Markman, John, et al.
Publicado: (2018)

Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies
por: Semel, David, et al.
Publicado: (2010)

Integrating Machine Learning With Microsimulation to Classify Hypothetical, Novel Patients for Predicting Pregabalin Treatment Response Based on Observational and Randomized Data in Patients With Painful Diabetic Peripheral Neuropathy
por: Alexander Jr, Joe, et al.
Publicado: (2019)

The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain
por: Parsons, Bruce, et al.
Publicado: (2019)

Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
por: Prnjavorac, Besim, et al.
Publicado: (2023)

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across a range of doses
por: Freeman, Roy, et al.
Publicado: (2008)

Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients
por: Parsons, Bruce, et al.
Publicado: (2018)

Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2012)

Pregabalin in Chemotherapy Induced Neuropathic Pain
por: Atreya, Shrikant
Publicado: (2016)

Morphine and pregabalin in the treatment of neuropathic pain
por: Wang, Yue, et al.
Publicado: (2017)

A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain
por: Shah, Islam, et al.
Publicado: (2022)

Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications
por: Freynhagen, Rainer, et al.
Publicado: (2021)

Retraction: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2014)

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
por: Haanpää, M., et al.
Publicado: (2015)

A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
por: Srivastava, A., et al.
Publicado: (2012)

Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
por: Verma, Vivek, et al.
Publicado: (2014)

Using time series analysis approaches for improved prediction of pain outcomes in subgroups of patients with painful diabetic peripheral neuropathy
por: Alexander, Joe, et al.
Publicado: (2018)

Pregabalin in Treatment-Refractory Fibromyalgia
por: Stacey, Brett R, et al.
Publicado: (2010)

Correction: Using time series analysis approaches for improved prediction of pain outcomes in subgroups of patients with painful diabetic peripheral neuropathy
por: Alexander, Joe, et al.
Publicado: (2019)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009)

Synergistic Antinociceptive Effects of Indomethacin–Pregabalin and Meloxicam–Pregabalin in Paclitaxel-Induced Neuropathic Pain
por: Ma, Yurong, et al.
Publicado: (2022)

Clinical use of pregabalin in the management of central neuropathic pain
por: Finnerup, Nanna B, et al.
Publicado: (2007)

Pregabalin in post traumatic neuropathic pain: Case studies
por: Singh, Rakesh Kumar, et al.
Publicado: (2012)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
por: Gül, Şule Karabulut, et al.
Publicado: (2020)

Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial
por: Han, Kyung Ah, et al.
Publicado: (2022)

Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
por: Joharchi, Khojasteh, et al.
Publicado: (2019)

The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
por: Wang, Bruce C. M., et al.
Publicado: (2016)

Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland
por: Mankowski, Colette, et al.
Publicado: (2016)

Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity
por: Sicras‐Mainar, Antoni, et al.
Publicado: (2016)

Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
por: Joharchi, Khojasteh, et al.
Publicado: (2019)

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022)

Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain
por: Cruccu, G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m9i4vluur1kudhqemqk4tqsq4a